DK311485D0 - Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin - Google Patents

Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin

Info

Publication number
DK311485D0
DK311485D0 DK311485A DK311485A DK311485D0 DK 311485 D0 DK311485 D0 DK 311485D0 DK 311485 A DK311485 A DK 311485A DK 311485 A DK311485 A DK 311485A DK 311485 D0 DK311485 D0 DK 311485D0
Authority
DK
Denmark
Prior art keywords
coli
toxic
substance
formulated
preparing non
Prior art date
Application number
DK311485A
Other languages
English (en)
Other versions
DK311485A (da
Inventor
John D Clements
Original Assignee
Praxis Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Praxis Biolog Inc filed Critical Praxis Biolog Inc
Publication of DK311485D0 publication Critical patent/DK311485D0/da
Publication of DK311485A publication Critical patent/DK311485A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1239—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Vibrionaceae (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK311485A 1984-07-09 1985-07-08 Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin DK311485A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62887384A 1984-07-09 1984-07-09

Publications (2)

Publication Number Publication Date
DK311485D0 true DK311485D0 (da) 1985-07-08
DK311485A DK311485A (da) 1986-01-10

Family

ID=24520666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK311485A DK311485A (da) 1984-07-09 1985-07-08 Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin

Country Status (10)

Country Link
EP (1) EP0168322B1 (da)
JP (1) JPS62500073A (da)
AT (1) ATE62270T1 (da)
AU (1) AU598725B2 (da)
CA (1) CA1340372C (da)
DE (1) DE3582373D1 (da)
DK (1) DK311485A (da)
ES (1) ES8703526A1 (da)
IE (1) IE59393B1 (da)
WO (1) WO1986000647A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
AR241713A1 (es) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
JPH0737464B2 (ja) * 1986-04-30 1995-04-26 イゲン，インコーポレーテッド エレクトロ化学ルミネセンスアツセイ
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
ATE218797T1 (de) * 1988-09-06 2002-06-15 Univ Washington Orale-immunisierung durch verwendung von transgenen pflanzen
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
DE3843894A1 (de) * 1988-12-24 1990-06-28 Behringwerke Ag Plasmide mit translations-start-stop-start codon-konfiguration zur expression von proteinen in e.coli
JPH03187383A (ja) * 1989-09-04 1991-08-15 Takeda Chem Ind Ltd 発現プラスミドおよびその用途
ES2376010T3 (es) 2006-10-12 2012-03-08 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. Prote�?na de fusión de transcriptasa inversa de la telomerasa, nucleótidos que la codifican y usos de la misma.
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328209A (en) * 1979-04-11 1982-05-04 Board Of Regents, The University Of Texas System Cholera vaccine
US4361550A (en) * 1979-12-04 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human suppressor T cells and methods of preparing same
NL8000527A (nl) * 1980-01-29 1981-08-17 Stichting Vrienden Van De Stic Werkwijze voor het bevorderen van hybridisatie van cellen in vitro en van de produktie en uitscheiding van stoffen, gevormd door dergelijke celhybriden, werkwijze voor het bevorderen van de produktie van monoclonale antilichamen in vitro door toepassing van een hybridomatechniek, alsmede endotheelcellen en/of supernatant van endotheelcellen.
US4427653A (en) * 1981-01-26 1984-01-24 President And Fellows Of Harvard College Method of making monoclonal antibodies
WO1982003088A1 (en) * 1981-03-09 1982-09-16 Corp Cetus Vaccines
US4411888A (en) * 1981-06-22 1983-10-25 The University Of Rochester Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic Escherichia coli
EP0084522A3 (de) * 1982-01-18 1983-10-19 Sandoz Ag Neue Plasmide und Bakterienstämme sowie Verfahren zu ihrer Herstellung
JPS58146596A (ja) * 1982-02-25 1983-09-01 Takeda Chem Ind Ltd 組換えｄｎａ、それで形質転換させた微生物およびそれらの用途
US4666837A (en) * 1982-05-24 1987-05-19 Smithkline-Rit DNA sequences, recombinant DNA molecules and processes for producing the A and B subunits of cholera toxin and preparations containing so-obtained subunit or subunits
US4882278A (en) * 1983-04-29 1989-11-21 President And Fellows Of Harvard College Non-toxinogenic vibrio cholerae mutants
US4637980A (en) * 1983-08-09 1987-01-20 Smithkline Beckman Corporation Externalization of products of bacteria
GB8333131D0 (en) * 1983-12-12 1984-01-18 Glaxo Group Ltd Microbiological process
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers

Also Published As

Publication number Publication date
DE3582373D1 (de) 1991-05-08
ATE62270T1 (de) 1991-04-15
EP0168322A3 (en) 1986-11-20
CA1340372C (en) 1999-02-02
DK311485A (da) 1986-01-10
AU4458785A (en) 1986-01-16
EP0168322A2 (en) 1986-01-15
JPS62500073A (ja) 1987-01-16
IE59393B1 (en) 1994-02-23
ES544967A0 (es) 1987-02-16
IE851710L (en) 1986-01-09
ES8703526A1 (es) 1987-02-16
EP0168322B1 (en) 1991-04-03
AU598725B2 (en) 1990-07-05
WO1986000647A1 (en) 1986-01-30

Similar Documents

Publication Publication Date Title
DK311485D0 (da) Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin
FI102382B1 (fi) Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten
FI943171A (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
DK582689A (da) Fremgangsmaade til paavisning af aids-infektion og proevesaet til anvendelse ved fremgangsmaaden
DK489581A (da) Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling
DZ634A1 (fr) Mutants de vibrio cholerale non-toxinogènes.
DK1398379T3 (da) Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
DK346783A (da) Triphenylimidazolyloxyalkansyrer og derivater deraf, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
DK505983A (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf
DK495683A (da) Beta-carboliner, fremgangsmaade til fremstilling af samme og farmaceutisk praeparat indeholdende samme
NO904538L (no) Kimaere glykoproteiner inneholdende immunogene segmenter av humant parainfluensavirus type 3.
DK0787796T3 (da) Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner
DK0485463T3 (da) Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde
DK621688A (da) Ethylerede avermectiner og praeparater indeholdende disse til behandling og forhindring af parasitinfektioner hos mennesker og dyr
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
DK555281A (da) Trifluormethoxyphenyl-thiophosphorsyreestere og dihtiohosphorsyreestere samt fremgangsmaade til fremstilling heraf
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
DK230890A (da) Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m.
DK306479A (da) N-cyclohexyl-n-methoxyacetoacetamid, fremgangsmaade til fremstilling deraf og anvendelse deraf til fremstilling af o-methyl-n-cyclohexyl-2,5-dimethylfuran-3-hydroxamsyre

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment